Dare Bioscience, Inc. · Drugmakers

DARE

High riskNext report: Around Nov 12 (est.)

View price ↗

The short version

A company still losing money, with elevated risk. Institutions are adding.

Going well

Little debt

Watch out for

Losing money, losses are large next to sales
3 offering filings in 6 months (may sell new shares)

Money moves

No insider buying or selling in the last 30 days
Institutions added 27% to their holdings in the quarter ending June 2026 (18 bought, 9 sold)

Facts from SEC filings, not a recommendation.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$188K

Sep '23Tap a barJun '26

Last 12 months: $1.4M.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

1/5Weak

PassDebt under half of equityNot relying on borrowed money.0.00x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.Losses many times its sales
MissProfitable every yearSteady profits, not one good year.0 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$10.3M
MissShare count not growingNot diluting owners. Falling means buybacks.+5.7% in 3 years

Revenue: $1.0M
Total debt: $11K; 0.00x equity
Current ratio: 1.14x; short-term assets / bills due
Free cash flow: -$10.3M; -997.0% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 13

Revenue: $188K
EPS: -$0.20; vs -$0.45
Op. margin: -1582.5%
Gross margin: -70.6%
Free cash flow: -$6.9M
Share count: +67.8%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 1
Normal week: 1.4
vs normal: 0.7x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+27.0%

Institutions added 27.0% to their holdings. 18 bought, 9 sold. 7 quarters of net buying in a row.

Shares held by institutions1.3M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+27.7%

Cash runwayAt last year's cash burn

15 months

Debt to equityLatest balance sheet: debt compared with what owners have

Owes more than it owns

Shares outstandingLatest reported

15M

Why high risk

Losing money, losses are large next to sales
About 15 months of cash left at its current burn
Share count growing 27.7% a year (dilution)
Owes more than it owns (negative equity)
Bills due within a year exceed short-term assets
6 offering filings in 6 months (may sell new shares)
Exchange listing notice (a delisting warning or a move to another exchange)

Earnings reports

Last 12

Next reportAround Nov 12 (est.)Estimated from the same quarter last year

Results filedAug 13
Results filedMay 14
Results filedMar 26
Results filedNov 13, 2025
Results filedAug 14, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Listing standards noticeOct 2 · View filing ↗Red flag Offering prospectusSep 4 · View filing ↗Offering New 5%+ holder (passive)Aug 28 · View filing ↗Big holder Share offering registrationAug 26 · View filing ↗Offering New 5%+ holder (passive)Aug 24 · View filing ↗Big holder Major agreementAug 17 · View filing ↗Offering Offering prospectusAug 17 · View filing ↗Offering Listing standards noticeJul 17 · View filing ↗Red flag Unregistered share saleMay 18 · View filing ↗Offering Unregistered share saleMay 7 · View filing ↗Offering

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

DEFA14AOct 27 · Form DEFA14A ↗Proxy statementOct 6 · Form DEF 14A ↗Listing standards noticeOct 2 · Form 8-K ↗Investor disclosureOct 1 · Form 8-K ↗PRE 14ASep 23 · Form PRE 14A ↗Charter or share changeSep 11 · Form 8-K ↗Investor disclosureSep 9 · Form 8-K ↗Offering prospectusSep 4 · Form 424B3 ↗EFFECTSep 3 · Form EFFECT ↗New 5%+ holder (passive)Aug 28 · Form SCHEDULE 13G ↗Share offering registrationAug 26 · Form S-1 ↗New 5%+ holder (passive)Aug 24 · Form SCHEDULE 13G ↗DAug 20 · Form D ↗253G2Aug 19 · Form 253G2 ↗Offering prospectusAug 17 · Form 424B5 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page